Detection and staining of 22 batches of Chinese Herbal Pieces

Not only foreign pharmaceutical companies, but also the traditional Chinese medicine industry hasn't stopped this year The reporter found that two pieces of "good news" and one piece of "bad news" came to this plate recently: the good news is that the guiding document of health service industry, which was allocated 1.49 billion yuan by the central government to promote the development of Chinese medicine and was newly released, clearly emphasized the importance of the development of Chinese medicine; the "black swan" was found that some pieces of Chinese medicine were stained because of the food and drug administration Good news: the central government allocated 1.49 billion yuan to the first health service guidance document issued by the State Council, and the "money bag" of the central government has been implemented According to the website of the Ministry of finance, the central government allocated 1.49 billion yuan to promote the development of traditional Chinese medicine "This 1.49 billion yuan of public health subsidy from TCM departments in 2013 will be used to support local governments to improve the appropriate technical service capacity of TCM, enhance the prevention, health care, rehabilitation and clinical service capacity of TCM, build the specialized departments with TCM characteristics in rural medical institutions, and build the service capacity of TCM at the county level." The Ministry of Finance specifically points out this Negative: the dyeing of Chinese herbal pieces will be investigated For the whole Chinese herbal medicine industry, this year is the "year of rectification" for the quality of Chinese herbal medicines, and even serious enough that no new professional market for Chinese herbal medicines has been allowed to open However, some difficulties will affect the trust and favor of consumers and investors in the whole industry According to the website of the State Food and drug administration, the State Food and Drug Administration recently organized a special spot check on the illegal dyeing of Chinese herbal pieces According to the work plan of the special action of "two dozen and two constructions", the General Administration organized the sampling of some pieces of Chinese herbal medicines produced, operated or used by relevant units in Anhui, Gansu, Guangdong and Sichuan provinces A total of 397 batches were sampled for special spot check, and 22 batches were confirmed to have dyeing problems, involving 3 varieties of safflower, yanhusuo and safflower The General Administration has ordered to investigate and deal with the Chinese herbal pieces and relevant units that were confirmed to have dyeing problems in spot check according to law In addition, the State Administration of food and drug administration, the Ministry of industry and information technology, the Ministry of agriculture, the Ministry of Commerce and other eight departments recently jointly issued opinions on Further Strengthening the management of traditional Chinese medicine, requiring that the primary processing of traditional Chinese medicine in the production area is strictly prohibited from abusing sulfur fumigation and other methods, and that the residues of sulfur dioxide and other substances must comply with the state regulations; in the future, no new specialized market of traditional Chinese medicine shall be opened in any place; and the no certificate will be firmly banned The illegal dens for production and operation of Chinese herbal pieces shall be severely cracked down on the illegal processing and disguised production of Chinese herbal pieces, such as illegal cutting and indiscriminate production The rectification of capital market affects the short-term performance, but the third quarter report is still high in anticipation "The rectification of the industry and exposure of many problems, some of the medicinal materials or products in the short-term performance will decline, but in the long run, the rectification is conducive to the development of traditional Chinese Medicine." Long Muheng, director of the Department of traditional Chinese medicine of the otolaryngology research center of Guangdong Armed Police Hospital, told reporters that in the medium and long term, he is still optimistic about the investment of traditional Chinese medicine shares After the sharp rise the day before yesterday, the stock price of traditional Chinese medicine generally fell, and the reporter learned that medicine belongs to the industry with the highest rate of expected gratification in the current three quarter report, especially the performance of traditional Chinese medicine companies "It is expected that in the future, the traditional Chinese medicine sector will continue to repair the valuation in the process of adjustment It is suggested that investors focus on the stocks with exclusive basic medicine varieties, such as Tianshili, Kangyuan pharmaceutical, Yibai pharmaceutical, etc.; or the enterprises with variety advantages, such as Baiyunshan, Ma Yinglong, Yunnan Baiyao, dong'a-jiao, etc." A pharmaceutical industry analyst told this newspaper that investors should also pay attention to the situation of local supplements Many pharmaceutical companies that have added the latest products to the local essential drug catalog may also have large performance in the second half of the year.